Clinical trial

Research In Viral Eradication of HIV Reservoirs

NCT02336074

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-11-27

PhasePHASE2

Study timeline

Study start (actual)2015-11-27Date precision: day

Registry last updated2023-10-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

Combination Antiretroviral Therapy (cART)DRUG

RaltegravirDRUG · verified · RxNorm: raltegravir

VorinostatDRUG · verified · RxNorm: vorinostat

ChAdV63.HIVconsv (ChAd)BIOLOGICAL

MVA.HIVconsv (MVA)BIOLOGICAL

Sponsors & collaborators

Imperial College Londonlead sponsor

Medical Research Councilcollaborator

University of Oxfordcollaborator

University of Cambridgecollaborator

Chelsea and Westminster NHS Foundation Trustcollaborator

Royal Free Hospital NHS Foundation Trustcollaborator

Brighton and Sussex University Hospitals NHS Trustcollaborator

Guy's and St Thomas' NHS Foundation Trustcollaborator

Central and North West London NHS Foundation Trustcollaborator

Mapped research locations

LondonUnited Kingdom5

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02336074 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.